Axxcess Wealth Management LLC boosted its holdings in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 38.5% during ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 17.28% ...

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...

Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500 The Ark Innovation and Ark Genomic ETFs turn ten years old. A look at the annual returns ...

Sphere Fluidics, a leading provider of innovative droplet-based microfluidics solutions for functional profiling of single ...

Kyle Mikson CFA, an analyst from Canaccord Genuity, maintained the Buy rating on Lucid Diagnostics (LUCD – Research Report). The ...

In a report released today, Tejas Savant from Morgan Stanley maintained a Buy rating on Guardant Health (GH – Research Report), with a ...

Based on offerings, the genomics market is divided into product and service segments. The product segment accounted for the largest share of the genomics market in 2023. This dominance is primarily ...

Leerink Partners has recently initiated 10X Genomics Inc (TXG) stock to Outperform rating, as announced on September 3, 2024, according to Finviz. Earlier, on July 22, 2024, Jefferies had raised the ...

To grasp the amount of firepower that Russia has unleashed on Ukraine, consider these numbers: An average of 23 missiles and attack drones per day have pummeled Ukraine between September 2022 and ...